- Home
- GLDD vs KALV Comparison
GLDD vs KALV Comparison
Compare GLDD & KALV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLDD
- KALV
- Stock Information
- Founded
- GLDD 1890
- KALV N/A
- Country
- GLDD United States
- KALV United States
- Employees
- GLDD N/A
- KALV N/A
- Industry
- GLDD Military/Government/Technical
- KALV Biotechnology: Pharmaceutical Preparations
- Sector
- GLDD Industrials
- KALV Health Care
- Exchange
- GLDD Nasdaq
- KALV Nasdaq
- Market Cap
- GLDD 770.3M
- KALV 642.3M
- IPO Year
- GLDD 2006
- KALV N/A
- Fundamental
- Price
- GLDD $11.71
- KALV $12.15
- Analyst Decision
- GLDD Buy
- KALV Strong Buy
- Analyst Count
- GLDD 1
- KALV 8
- Target Price
- GLDD $14.00
- KALV $24.83
- AVG Volume (30 Days)
- GLDD 512.8K
- KALV 831.5K
- Earning Date
- GLDD 08-05-2025
- KALV 07-10-2025
- Dividend Yield
- GLDD N/A
- KALV N/A
- EPS Growth
- GLDD 79.53
- KALV N/A
- EPS
- GLDD 1.02
- KALV N/A
- Revenue
- GLDD $806,898,000.00
- KALV N/A
- Revenue This Year
- GLDD $9.62
- KALV N/A
- Revenue Next Year
- GLDD $5.83
- KALV N/A
- P/E Ratio
- GLDD $11.46
- KALV N/A
- Revenue Growth
- GLDD 28.03
- KALV N/A
- 52 Week Low
- GLDD $7.51
- KALV $7.30
- 52 Week High
- GLDD $12.89
- KALV $15.50
- Technical
- Relative Strength Index (RSI)
- GLDD 60.81
- KALV 44.01
- Support Level
- GLDD $11.41
- KALV $11.11
- Resistance Level
- GLDD $11.76
- KALV $13.38
- Average True Range (ATR)
- GLDD 0.27
- KALV 0.77
- MACD
- GLDD -0.04
- KALV -0.17
- Stochastic Oscillator
- GLDD 73.42
- KALV 4.90
About GLDD Great Lakes Dredge & Dock Corporation
Great Lakes Dredge & Dock Corp is a provider of dredging services in the United States. The Company is also fully engaged in expanding its core business into the offshore energy industry. Dredging involves the enhancement or preservation of the navigability of waterways or the protection of shorelines through the removal or replenishment of soil, sand, or rock. Company work generally is to performed in coastal waterways and deep water ports. Its project portfolio includes Coastal Restoration, Coastal Protection, Ports and Harbors, International, and Inland Dredging.
About KALV KalVista Pharmaceuticals Inc.
KalVista Pharmaceuticals Inc is a pharmaceutical company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema and diabetic macular edema; and oral plasma kallikrein inhibitors. Geographically it operates throughout the region of the United States. The company is also conducting preclinical development on a novel, oral, Factor XIIa inhibitor program.